Baker Bros. Advisors (GP) LLC — SEC insider filings

SEC reporting owner CIK 1580575. 212 insider filings on record with FilingPulse; latest filed 2026-11-06.

Transaction summary — filings shown

Covers the 50 most recent of 212 filings on record, filed 2025-06-12 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Celcuity Inc. (CELC)—24 legs · 170,100 sh · $9,571,3192 legs · 3,100,000 sh · $317,750,000—
Kodiak Sciences Inc. (KOD)Director, 10% owner788 legs · 4,797,541 sh · $241,327,238—4
Kymera Therapeutics, Inc. (KYMR)Director, 10% owner44 legs · 2,661,313 sh · $201,341,918—6
MADRIGAL PHARMACEUTICALS, INC. (MDGL)Director559 legs · 257,489 sh · $96,944,056—8
Entrada Therapeutics, Inc. (TRDA)10% owner216 legs · 206,911 sh · $1,614,433——
KALA BIO, Inc. (KALA)—1—4 legs · 730,408 sh · $1,056,722—
BeOne Medicines Ltd. (ONC)Director2—4 legs · 10,998 sh · $261,9812
INCYTE CORP (INCY)Director, 10% owner9——24
vTv Therapeutics Inc. (VTVT)Director3——10
Denali Therapeutics Inc. (DNLI)Director2——6

+8 more issuers among the filings shown — every filing appears in the table below.

Insider filings — Baker Bros. Advisors (GP) LLC

FiledFormIssuerReported transactionsSource
2026-11-064Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 8,742 @ $98.51 · Purchase (P): 151,916 @ $98.51 · Purchase (P): 4,703 @ $98.51 · Purchase (P): 81,729 @ $98.51EDGAR
2026-11-064MADRIGAL PHARMACEUTICALS, INC. (MDGL)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, 667, L.P., Baker Brothers Life Sciences LP
Purchase (P): 5,586 @ $366.99 · Purchase (P): 10,080 @ $368.11 · Purchase (P): 60,400 @ $383.01 · Purchase (P): 13,740 @ $388.29 · Purchase (P): 2,000 @ $396.61EDGAR
2026-10-024INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 322 @ $0 · Grant/award (A): 322 @ $0EDGAR
2026-09-304Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 534 @ $79.40 · Purchase (P): 8,956 @ $79.40 · Purchase (P): 17 @ $79.63 · Purchase (P): 283 @ $79.63 · Purchase (P): 884 @ $79.71 · Purchase (P): 14,827 @ $79.71 · +24 moreEDGAR
2026-09-304Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 856 @ $61.21 · Purchase (P): 14,344 @ $61.21 · Purchase (P): 2,666 @ $61.63 · Purchase (P): 44,690 @ $61.63 · Purchase (P): 243 @ $62.96 · Purchase (P): 4,067 @ $62.96 · +24 moreEDGAR
2026-09-304Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 186 @ $86.72 · Purchase (P): 3,114 @ $86.72 · Purchase (P): 957 @ $86.81 · Purchase (P): 16,036 @ $86.81 · Purchase (P): 3,790 @ $86.94 · Purchase (P): 63,539 @ $86.94 · +16 moreEDGAR
2026-08-114Replimune Group, Inc. (REPL)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 126,394 (derivative) @ $12.06 · Purchase (P): 2,609,946 (derivative) @ $12.06EDGAR
2026-07-164Celcuity Inc. (CELC)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN
Sale (S): 261,368 @ $102.50 · Sale (S): 2,838,632 @ $102.50EDGAR
2026-07-024INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 400 @ $0 · Grant/award (A): 400 @ $0EDGAR
2026-07-024Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 17,731 (derivative) @ $0 · Grant/award (A): 17,731 (derivative) @ $0EDGAR
2026-06-294vTv Therapeutics Inc. (VTVT)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2026-06-254Kymera Therapeutics, Inc. (KYMR)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 6,068 (derivative) @ $0 · Grant/award (A): 6,068 (derivative) @ $0EDGAR
2026-06-184MADRIGAL PHARMACEUTICALS, INC. (MDGL)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 908 @ $0 · Grant/award (A): 908 @ $0 · Grant/award (A): 1,532 (derivative) @ $0 · Grant/award (A): 1,532 (derivative) @ $0EDGAR
2026-06-154BeOne Medicines Ltd. (ONC)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 18,980 @ $0 · Grant/award (A): 18,980 @ $0EDGAR
2026-06-104INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 1,642 @ $0 · Grant/award (A): 1,642 @ $0 · Grant/award (A): 6,111 (derivative) @ $0 · Grant/award (A): 6,111 (derivative) @ $0EDGAR
2026-06-104Prelude Therapeutics Inc (PRLD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 38,000 (derivative) @ $0 · Grant/award (A): 38,000 (derivative) @ $0EDGAR
2026-06-054Denali Therapeutics Inc. (DNLI)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 6,408 @ $0 · Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 · Grant/award (A): 19,226 (derivative) @ $0EDGAR
2026-06-024ACADIA PHARMACEUTICALS INC (ACAD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 18,622 @ $0 · Grant/award (A): 18,622 @ $0 · Grant/award (A): 32,008 (derivative) @ $0 · Grant/award (A): 32,008 (derivative) @ $0EDGAR
2026-06-024Kiniksa Pharmaceuticals International, plc (KNSA)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 6,078 @ $0 · Grant/award (A): 6,078 @ $0 · Grant/award (A): 36,474 (derivative) @ $0 · Grant/award (A): 36,474 (derivative) @ $0EDGAR
2026-05-274BeOne Medicines Ltd. (ONC)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Sale (S): 2,743 @ $23.85 · Sale (S): 2,743 @ $23.85 · Sale (S): 2,756 @ $23.79 · Sale (S): 2,756 @ $23.79EDGAR
2026-05-224TScan Therapeutics, Inc. (TCRX)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 67,000 (derivative) @ $0 · Grant/award (A): 67,000 (derivative) @ $0EDGAR
2026-05-114INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Option exercise (M): 15,000 @ $84.53 · Option exercise (M): 15,000 @ $84.53 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-04-224Prelude Therapeutics Inc (PRLD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 114,601 (derivative) @ $4.44 · Purchase (P): 2,137,651 (derivative) @ $4.44EDGAR
2026-04-074Replimune Group, Inc. (REPL)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 44,500 (derivative) @ $0 · Grant/award (A): 44,500 (derivative) @ $0EDGAR
2026-04-024INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 421 @ $0 · Grant/award (A): 421 @ $0EDGAR
2026-01-144DBV Technologies S.A. (DBVT)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Option exercise (M): 2,299,656 (derivative) @ $0 · Option exercise (M): 25,005,240 (derivative) @ $0 · Option exercise (M): 2,299,656 (derivative) @ $0 · Option exercise (M): 25,005,240 (derivative) @ $0EDGAR
2026-01-064BICYCLE THERAPEUTICS PLC (BCYC)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 19,000 @ $0 · Grant/award (A): 19,000 @ $0 · Grant/award (A): 38,000 (derivative) @ $0 · Grant/award (A): 38,000 (derivative) @ $0EDGAR
2026-01-054INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 328 @ $0 · Grant/award (A): 328 @ $0EDGAR
2025-12-194Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 217,428 @ $23 · Purchase (P): 2,391,268 @ $23EDGAR
2025-12-154Denali Therapeutics Inc. (DNLI)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 190,523 (derivative) @ $17.49 · Purchase (P): 2,095,191 (derivative) @ $17.49EDGAR
2025-12-114Kymera Therapeutics, Inc. (KYMR)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 167,192 @ $86 · Purchase (P): 1,838,621 @ $86EDGAR
2025-11-244Entrada Therapeutics, Inc. (TRDA)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 1,213 @ $9.07 · Purchase (P): 13,386 @ $9.07 · Purchase (P): 1,186 @ $9.07 · Purchase (P): 13,082 @ $9.07EDGAR
2025-11-124Entrada Therapeutics, Inc. (TRDA)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 2,296 @ $7.21 · Purchase (P): 25,364 @ $7.21 · Purchase (P): 267 @ $7.22 · Purchase (P): 2,947 @ $7.22 · Purchase (P): 1,059 @ $7.39 · Purchase (P): 11,701 @ $7.39 · +6 moreEDGAR
2025-10-024INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 388 @ $0 · Grant/award (A): 388 @ $0EDGAR
2025-10-024KALA BIO, Inc. (KALA)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN
Sale (S): 21,376 @ $1.60 · Sale (S): 195,425 @ $1.60 · Sale (S): 50,640 @ $1.38 · Sale (S): 462,967 @ $1.38EDGAR
2025-09-104Celcuity Inc. (CELC)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 13,976 @ $56.22 · Purchase (P): 151,524 @ $56.22 · Purchase (P): 388 @ $58.02 · Purchase (P): 4,212 @ $58.02EDGAR
2025-09-054vTv Therapeutics Inc. (VTVT)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 4,308 · Grant/award (A): 46,692 · Grant/award (A): 217,144 (derivative) · Grant/award (A): 2,353,913 (derivative) · Grant/award (A): 221,452 (derivative) · Grant/award (A): 2,400,605 (derivative)EDGAR
2025-08-204MADRIGAL PHARMACEUTICALS, INC. (MDGL)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, 667, L.P., Baker Brothers Life Sciences LP
Purchase (P): 177 @ $353.88 · Purchase (P): 1,923 @ $353.88 · Purchase (P): 84 @ $355 · Purchase (P): 916 @ $355 · Purchase (P): 767 @ $357.02 · Purchase (P): 8,328 @ $357.02 · +22 moreEDGAR
2025-08-204MADRIGAL PHARMACEUTICALS, INC. (MDGL)
jointly with BAKER BROS. ADVISORS LP, BAKER FELIX, BAKER JULIAN, 667, L.P., Baker Brothers Life Sciences LP
Purchase (P): 2,460 @ $372.87 · Purchase (P): 26,704 @ $372.87 · Purchase (P): 675 @ $374.43 · Purchase (P): 7,325 @ $374.43 · Purchase (P): 480 @ $380.44 · Purchase (P): 5,209 @ $380.44 · +20 moreEDGAR
2025-08-184IGM Biosciences, Inc. (IGMS)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Code (U): 357,048 · Code (U): 3,763,362 · Code (U): 834,707 (derivative) @ $0 · Code (U): 9,886,217 (derivative) @ $0EDGAR
2025-07-024Kodiak Sciences Inc. (KOD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-07-024TScan Therapeutics, Inc. (TCRX)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 67,000 (derivative) @ $0 · Grant/award (A): 67,000 (derivative) @ $0EDGAR
2025-07-024INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 492 @ $0 · Grant/award (A): 492 @ $0EDGAR
2025-07-024IGM Biosciences, Inc. (IGMS)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 953 @ $0 · Grant/award (A): 953 @ $0EDGAR
2025-06-304Kymera Therapeutics, Inc. (KYMR)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Purchase (P): 55,191 @ $44 · Purchase (P): 600,309 @ $44 · Purchase (P): 55,191 (derivative) @ $44.00 · Purchase (P): 600,309 (derivative) @ $44.00EDGAR
2025-06-264Kymera Therapeutics, Inc. (KYMR)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 16,000 (derivative) @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-06-244MADRIGAL PHARMACEUTICALS, INC. (MDGL)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 1,430 @ $0 · Grant/award (A): 1,430 @ $0 · Grant/award (A): 2,580 (derivative) @ $0 · Grant/award (A): 2,580 (derivative) @ $0EDGAR
2025-06-134Prelude Therapeutics Inc (PRLD)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 76,000 (derivative) @ $0 · Grant/award (A): 76,000 (derivative) @ $0EDGAR
2025-06-124vTv Therapeutics Inc. (VTVT)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 4,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2025-06-124INCYTE CORP (INCY)
jointly with BAKER BROS. ADVISORS LP, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN
Grant/award (A): 2,518 @ $0 · Grant/award (A): 2,518 @ $0 · Grant/award (A): 9,216 (derivative) @ $0 · Grant/award (A): 9,216 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1580575 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs